BOCGAS • NSE

BOC Gases Plc

13.75

NGN

Open Price

13.75

Previous Close

13.75

Today’s Range

13.75 - 13.75

Number of Deals

3.0

Volume Traded

5,045.00

Value Traded

62,596.00

52 Weeks High

14.75

52 Weeks Low

7.30

Market Cap

5,723,364,707.50

YTD Price Performance

88.36 %

Industrial & Medical Gases Nigeria Plc Notifies of Resolutions Passed at Extra-Ordinary General Meeting

December 30th, 2022 at 11:27 AM

Industrial and Medical Gases Nigeria Reports N359.49m PAT in Q3 2022 Results, (Share Price: N7.4k)

November 4th, 2022 at 10:27 AM

Industrial and Medical Gases Nigeria Reports N268.8m PAT in Q2 2022 Results, (Share Price: N8.25k)

August 12th, 2022 at 7:44 PM

Industrial and Medical Gases Plc Appoints Mr. Aminu Ado as Acting Chairman

July 25th, 2022 at 9:42 PM

Industrial and Medical Gases Nigeria Plc Announces the Passing Away of the Chairman of the Board, Mr. Abiodun Olabode Alabi

June 30th, 2022 at 12:53 PM

Industrial & Medical Gases Nigeria Plc to Hold 63rd AGM on June 24, 2022

May 25th, 2022 at 9:27 PM

Key Stats

Shares Outstanding

416,244,706.00

Net Assets

3,184.00

Book Value Per Share

7.65

Sector P/E

44.35

EPS

0.31

P/E

44.35

ROE

0.00

Dividend Yield

2.18

About Company

Manufacture of Industrial and Medical Gases well as Marketing of Special Gass Welding and Medical Equipment

Sector

Natural Resources

Sub Sector

Chemicals

Management

Martins Esinulo

Adeshina Alayaki

Wasiu Onakoya

Bolaji Adisa

Ayodeji E. Oseni

Patric Iroko

Micheal Akinduro

Charles Chigbolu

Address

N/A

Phone No

Email Address

Website

Board of Directors

Hendrik Mentz De Waal

Abiodun Olabode Alabi

Ayodeji Oseni

Ben Mabelane

Adebayo Adeleke

Adeshina Alayaki

Abiodun Olabode Alabi

Olawale Oyeniyi Oyedele

Abiodun Olabode Alabi

Social Media Accounts

Subsidiary

Company Secretary

End of Accounting Year

31 Dec

Listing Date

01/11/1979

Company Registrar

Regulatory Status

Free Float

0.00

Auditor

Touche

Analyst Reports

Q1 2022 Unaudited Financial Statements for the Period ended 31st March 2021 –Industrial and Medical Gases Nigeria Plc

Industrial and Medical Gases Nigeria Plc released its Q1 2022 Unaudited results for the period ended March 31st, 2021. Revenue grew by 44.9% from N778m to N1.13bn, Profit before tax stood at N191.99m, Profit after tax stood at N130.58m, Share Price Currently Stands at N9.45k

May 8th, 2022 at 2:50 PM

2021 Audited Financial Statements for the Period ended 31st December 2021 – Industrial & Medical Gases Plc

Industrial and Medical Gases Nigeria Plc released its 2021 Audited results for the period ended December 31st, 2021. Revenue grew by 16.7% from N3.17bn to N3.70bn, Profit before tax stood at N552m, Profit after tax stood at N372.02m, Share Price Currently Stands at N9.45k

April 25th, 2022 at 9:55 AM

Income

Q2, 2022 and Q2, 2021 Financial Performance Comparison

Profit & loss information

Description	Q 2, 2022 N'm	Q 2, 2021 N'm	% Change
Gross Earnings	0.00	0.00	+ 0.00%
Profit Before Tax	192.00	0.00	+ 0.00%
Income Tax Expense	-62.00	-76.00	-18.42%
Taxation	-61.00	0.00	+ 0.00%
Profit After Tax	131.00	26.00	+ 403.85%
Fixed Assets	2,166.00	2,046.00	+ 5.87%
Total Assets	5,537.00	5,790.00	-4.37%
Customers Deposits	0.00	0.00	+ 0.00%
Loans and Advances	0.00	0.00	+ 0.00%
Total Liabilities	2,354.00	2,825.00	-16.67%
Borrowings	0.00	0.00	+ 0.00%
Cash Flow From Operating Activities	0.00	0.00	+ 0.00%

Income

Description	Q 2, 2022 N'm	Q 1, 2022 N'm	Q 4, 2021 N'm	Q 3, 2021 N'm	Q 2, 2021 N'm
Gross Earnings	0.00	0.00	0.00	0.00	0.00
Gross Premium Written	0.00	0.00	0.00	0.00	0.00
Revenue	1,128.00	1,128.00	3,699.00	2,758.00	1,771.00
Turnover	0.00	0.00	0.00	0.00	0.00
Interest And Similar Income	0.00	0.00	0.00	0.00	0.00
Gross Premium Income	0.00	0.00	0.00	0.00	0.00
Cost Of Sales	-512.00	-512.00	-1,677.00	-1,304.00	-865.00

Description	Q 2, 2022 N'm	Q 1, 2022 N'm	Q 4, 2021 N'm	Q 3, 2021 N'm	Q 2, 2021 N'm
Property Plant And Equipment	2,166.00	2,166.00	2,085.00	2,118.00	2,046.00
Fair Value Movements On Equity Instruments	0.00	0.00	0.00	0.00	0.00
Value Through Profit Or Loss	0.00	0.00	0.00	0.00	0.00
Intangible Assets	0.00	0.00	0.00	0.00	0.00
Fair Value Movements On Debt Securities	0.00	0.00	0.00	0.00	0.00
Management Expenses	0.00	0.00	0.00	0.00	0.00
Other Non Current Assets	0.00	0.00	0.00	0.00	0.00

Description	Q 4, 2021 N'm	Q 3, 2021 N'm	Q 2, 2021 N'm
Cash Flow From Operating Activities	0.00	0.00	0.00
Total Premium Received	0.00	0.00	0.00
Receipt From Reinsurance Recovery	0.00	0.00	0.00
Reinsurance Premium Paid	0.00	0.00	0.00
Profit For The Period	372.00	489.00	298.00
Commission Received	0.00	0.00	0.00
Claims Recoveries	0.00	0.00	0.00

Remark	Date
Company's accounts for 12 months ended 31st December, 2015 will be considered; it is also expected that the issue of dividend will be discussed	3/10/2016
To consider the audited accounts for the year ended 31 December 2014 and considerations for the declaration of dividend.	3/9/2015
The Directors will consider the Company's Accounts for the year ended December 31, 2010 and recommend the payment of dividend	3/11/2011

Dividend	Dividend Type	Announement Date	Payment Date	Date
0.30	Final	3/26/2020	6/26/2020	6/8/2020
0.40	Final	3/28/2019	6/21/2019	6/3/2019
0.10	Final	4/1/2015	6/15/2015	5/15/2015
0.10	Final	4/14/2014	7/7/2014	5/27/2014
0.20	Final	4/5/2013	7/8/2013	5/21/2013
0.36	Final	3/29/2011	7/4/2011	5/24/2011
0.30	Final	4/1/2010		6/1/2010
0.26				6/12/2009
0.22				5/30/2008
0.18				3/13/2007

Bonus	Bonus Type	Announement Date	Payment Date	Date
1 for 7	1 for 7	4/2/2012		4/2/2012

New Face Value	Old Face Value	Exsplit Date	Announement Date

Book Closure	Address	Announement Date	Date
6/8/2020	Ikeja Airport Hotel	3/26/2020	6/25/2020
6/3/2019	Ikeja Airport Hotel	3/28/2019	6/20/2019
5/15/2015	To be announced	4/1/2015	6/11/2015
5/27/2014	Lagos Airport Hotel, Ikeja.	4/14/2014	6/26/2014
5/21/2013	Lagos Airport Hotel, Ikeja	4/5/2013	6/13/2013
5/24/2011	Lagos Airport Hotel Ikeja.	4/1/2011	6/17/2011
6/1/2010		5/4/2010	6/23/2010
			6/24/2009
			5/15/2008

Technical Rating

Very Bullish
See details
View historical rating

Moving averages

Billish
Moving averages

Billish
Moving averages crossovers

Natural

Pivot levels

Trend	R1	R2	R3	PP	S1	S2	S3
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72

Note: This is just a sample text, change appropriately.

Moving average

Days
- HTML
- CSS
- JavaScript
5

1,344.77
10

1,344.77
20

1,344.77
50

1,344.77
100

1,344.77
200

1,344.77

Name of chart*

Technical Rating

Very Bullish
See details
View historical rating

Moving averages

Billish
Moving averages

Billish
Moving averages crossovers

Natural

Pivot levels

Trend	R1	R2	R3	PP	S1	S2	S3
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72

Note: This is just a sample text, change appropriately.

Moving average

Days
- HTML
- CSS
- JavaScript
5

1,344.77
10

1,344.77
20

1,344.77
50

1,344.77
100

1,344.77
200

1,344.77

Name of chart*

Technical Rating

Very Bullish
See details
View historical rating

Moving averages

Billish
Moving averages

Billish
Moving averages crossovers

Natural

Pivot levels

Trend	R1	R2	R3	PP	S1	S2	S3
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72
Classic	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72	1,565.72

Note: This is just a sample text, change appropriately.

Moving average

Days
- HTML
- CSS
- JavaScript
5

1,344.77
10

1,344.77
20

1,344.77
50

1,344.77
100

1,344.77
200

1,344.77

Name of chart*

Q 1, 2022

Price to book

1.80
Price to sales

5.07
Dividend yield

2.18
Net Debt

-1,527.00
Price Earning Including Extra Items

43.69
Price Earning Normalized

41.54
Price To Free Cash Flow

-17.56
Price To Tangible Book

1.03

Q 2, 2022

Price to book

1.80
Price to sales

5.07
Dividend yield

2.18
Net Debt

-1,527.00
Price Earning Including Extra Items

43.69
Price Earning Normalized

41.54
Price To Free Cash Flow

-17.56
Price To Tangible Book

1.03

Q 1, 2022

Gross Revenue Margin

145.39
Gross Profit Margin

145.39
Net Interest Margin

0.00
Net Profit Margin

11.61
Operating Cash Flow/Revenue

-28.90
Operating Profit Margin (%)

0.00
Pretax Margin

17.02

Q 2, 2022

Gross Revenue Margin

145.39
Gross Profit Margin

145.39
Net Interest Margin

0.00
Net Profit Margin

11.61
Operating Cash Flow/Revenue

-28.90
Operating Profit Margin (%)

0.00
Pretax Margin

17.02

Q 1, 2022

Book Value Growth Rate

4.29
Capital Expenditure Growth Rate

0.00
Deposit Growth

0.00
Dividend Growth

-25.00
EBITDA

0.00
EPS Growth Rate

-64.78
Fixed Asset Growth

3.88
Impairment Growth

0.00
Loan Growth

0.00
Net Assets growth

4.29
Net Profit Margin Growth Rate

-100.00
Operating Cash Flow

-326.00
Revenue Growth

-69.51
Shareholder Fund Growth

4.29
Total Assets Growth

-1.05
Total Liabilities Growth

-7.43

Q 2, 2022

Book Value Growth Rate

0.00
Capital Expenditure Growth Rate

0.00
Deposit Growth

0.00
Dividend Growth

-25.00
EBITDA

0.00
EPS Growth Rate

0.00
Fixed Asset Growth

3.88
Impairment Growth

0.00
Loan Growth

0.00
Net Assets growth

0.00
Net Profit Margin Growth Rate

-100.00
Operating Cash Flow

-326.00
Revenue Growth

0.00
Shareholder Fund Growth

0.00
Total Assets Growth

0.00
Total Liabilities Growth

0.00

Q 1, 2022

Book Value per share

7.65
Cash Per Share

3.67
Dividend Per Share

0.30
EPS Basic Excl. Extra Items

0.31
EPS Excl. Extra Items

0.31
EPS Incl. Extra Items

0.00
EPS Normalized

0.31
Revenue Per Share

2.71

Q 2, 2022

Book Value per share

7.65
Cash Per Share

3.67
Dividend Per Share

0.30
EPS Basic Excl. Extra Items

0.31
EPS Excl. Extra Items

0.31
EPS Incl. Extra Items

0.00
EPS Normalized

0.31
Revenue Per Share

2.71

Q 1, 2022

Acid Test Ratio

1.39
Claims Ratio

0.00
Cost to Income Ratio

0.00
Current Ratio

1.69
Investment Ratio

0.00
Leverage Ratio

0.00
Liquidity Ratio

0.28
Long Term Debt/Equity

0.00
Net Interest Coverage

0.00
Payout Ratio

0.95
Quick Ratio

1.39
Reserve Ratio

0.00
Total Debt/Total Equity

0.00

Q 2, 2022

Acid Test Ratio

1.39
Claims Ratio

0.00
Cost to Income Ratio

0.00
Current Ratio

1.69
Investment Ratio

0.00
Leverage Ratio

0.00
Liquidity Ratio

0.28
Long Term Debt/Equity

0.00
Net Interest Coverage

0.00
Payout Ratio

0.95
Quick Ratio

1.39
Reserve Ratio

0.00
Total Debt/Total Equity

0.00

Q 1, 2022

Annual % Change in Highest Directors Pay

-100.00
Annual % Change in PBT

-65.22
Annual % Change in Share Price

2.23
Annual % Change in Staff Cost

-100.00
Asset Turnover

0.20
Dividend Payout Ratio

0.95
Highest Directors’ Pay to PBT Ratio

0.00
Highest Directors’ Pay to Revenue Ratio

0.00
Highest Directors’ Pay vs PBT

0.00
Highest Directors’ Pay vs Revenue

0.00
Highest Directors’ Pay vs Staff Cost

0.00
Inventory Turnover

-0.89
Net Income/Employee

6.55
Receivables Turnover

0.00
Return on Assets

0.03
Return on Average Assets

0.02
Return on Average Equity

0.00
Return on Equity

0.00
Return on Investment

-0.19
Revenue/Employee

56.40
Staff Cost vs PBT

0.00
Staff Cost vs Revenue

0.00

Q 2, 2022

Annual % Change in Highest Directors Pay

0.00
Annual % Change in PBT

0.00
Annual % Change in Share Price

2.23
Annual % Change in Staff Cost

-100.00
Asset Turnover

0.20
Dividend Payout Ratio

0.95
Highest Directors’ Pay to PBT Ratio

0.00
Highest Directors’ Pay to Revenue Ratio

0.00
Highest Directors’ Pay vs PBT

0.00
Highest Directors’ Pay vs Revenue

0.00
Highest Directors’ Pay vs Staff Cost

0.00
Inventory Turnover

-0.89
Net Income/Employee

6.55
Receivables Turnover

0.00
Return on Assets

0.03
Return on Average Assets

0.02
Return on Average Equity

0.00
Return on Equity

0.00
Return on Investment

-0.19
Revenue/Employee

56.40
Staff Cost vs PBT

0.00
Staff Cost vs Revenue

0.00

Price performance

1 week

1 month

3 months

-4.51%

6 months

61.76%

9 months

56.25%

1 years

88.36%

Volume analysis

1 week

384.17%

1 month

-70.15%

3 months

-66.06%

6 months

-32.55%

9 months

-92.97%

1 years

-97.95%

RELATED MEDIA

SIMILAR STOCKS

Proshare is a professional practice focused on delivering research and information services to bridge the gap between investors and markets; by delivery on credible, reliable, and timely engagements through the following areas — Impact Research, Market Intelligence, Strategic Advisory, Stakeholder Relations & Digital Media.